Navigation Links
World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester

than Grigg Professor of Paediatric Respiratory and Environmental Medicine Institute of Cell and Molecular Science, Queen Mary University London Tel: 020 78822206

Dr Marcus Cooke, Radiation and Oxidative Stress Section Dept. Cancer Studies & Dept. Genetics University of Leicester Tel: 0116 2525825

ISSUED BY:

Ather Mirza Director of Press and Publications University of Leicester University Road Leicester LE1 7RH tel: 0116 252 3335 email: pressoffice@le.ac.uk Looking for an expert? Try http://www.le.ac.uk/press/experts/intro.html UNIVERSITY OF LEICESTER - A member of the 1994 Group of universities that share a commitment to research excellence, high quality teaching and an outstanding student experience. * England's top ranked University for teaching quality and overall satisfaction amongst universities teaching full time students - National Student Survey 2005 and 2006 * One of just 19 UK universities to feature in world's top 200- Shanghai Jiao Tong International Index, 2005 and 2006. Ranked as a Top 20 university by The Times Good University Guide. * Short listed Higher Education Institution of the Year - THES awards 2005 and 2006 * Students' Union of the Year award 2005, short listed 2006 Founded in 1921, the University of Leicester has 19,000 students from 120 countries. Teaching in 18 subject areas has been graded Excellent by the Quality Assurance Agency- including 14 successive scores - a consistent run of success matched by just one other UK University. Leicester is world renowned for the invention of DNA Fingerprinting by Professor Sir Alec Jeffreys and houses Europe's biggest academic Space Research Centre. 90% of staff are actively engaged in high quality research and 13 subject areas have been awarded the highest rating of 5* and 5 for research quality, demonstrating excellence at an international l
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
2. MAP Pharmaceuticals to Present Unit Dose Budesonide Phase 2 Clinical Data at the World Asthma Meeting
3. Active Biotech presents new pre-clinical data for the 57-57 project at the 8th World Congress on Inflammation
4. New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings
5. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
6. ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
7. Gentiums Defibrotide Highlighted in Poster Presentation at World Congress of Nephrology
8. Onconase has Potential as Chemopreventive Agent in Mesothelioma, Reports World-Renowned Mesothelioma Researcher at AACR Annual Meeting
9. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
10. Two-Year Patient Registry Results Support Safety and Efficacy of Cypher Sirolimus-Eluting Coronary Stent in Real World Uses
11. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
Post Your Comments:
(Date:5/4/2015)... 2015  Impax Laboratories, Inc. (NASDAQ: IPXL ) ... roles, appointing  Donna M. Hughes, as Senior Vice President, ... Senior Vice President, Chief Compliance Officer. Both Ms. Hughes ... Chief Executive Officer, Fred Wilkinson . ... the Impax team," said Fred Wilkinson , President ...
(Date:5/4/2015)... N.J. , May 4, 2015  Oncobiologics, ... commercializing monoclonal antibody (mAb) biosimilars, has completed the ... at its headquarters in Cranbury, New ... Cranbury facility is designed to utilize ... manufacturing at commercial scale.  Through the use of ...
(Date:5/4/2015)... N.Y. , May 4, 2015  Clinical ... Englert , PharmD, has completed preliminary analysis of ... and Schizophrenia. Resources from Clinical Support Services, Inc. ... Reviews (CMR) with patients currently taking psychiatric medications ... The research found that 93% of patients experienced ...
Breaking Medicine Technology:Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 2Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 3Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 2Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 3Clinical Support Services, Inc. Verifies That Increased Availability of MTM Services Facilitates Identification of Adverse Drug Effects in Psychiatric Patients 2Clinical Support Services, Inc. Verifies That Increased Availability of MTM Services Facilitates Identification of Adverse Drug Effects in Psychiatric Patients 3
... Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) today announced ... NBI-98854 in 37 tardive dyskinesia patients. For the final analysis, ... and incorrect application of the efficacy assessment protocol. With this ... dyskinesia symptoms at end of two weeks of active treatment ...
... treatment may target hunger at its source, another uses ... stomach and suppress hunger and a third explores the ... Initial results from all these studies were reported at ... in San Francisco, Calif. (Logo: ...
Cached Medicine Technology:Neurocrine Announces Phase II Results of VMAT2 Inhibitor NBI-98854 for Treatment of Tardive Dyskinesia 2Neurocrine Announces Phase II Results of VMAT2 Inhibitor NBI-98854 for Treatment of Tardive Dyskinesia 3Neurocrine Announces Phase II Results of VMAT2 Inhibitor NBI-98854 for Treatment of Tardive Dyskinesia 4Neurocrine Announces Phase II Results of VMAT2 Inhibitor NBI-98854 for Treatment of Tardive Dyskinesia 5Neurocrine Announces Phase II Results of VMAT2 Inhibitor NBI-98854 for Treatment of Tardive Dyskinesia 6Neurocrine Announces Phase II Results of VMAT2 Inhibitor NBI-98854 for Treatment of Tardive Dyskinesia 7No Pain, No Gain: Weight Loss, Disc Disease Interventional Radiology Treatments Coming 2No Pain, No Gain: Weight Loss, Disc Disease Interventional Radiology Treatments Coming 3No Pain, No Gain: Weight Loss, Disc Disease Interventional Radiology Treatments Coming 4No Pain, No Gain: Weight Loss, Disc Disease Interventional Radiology Treatments Coming 5No Pain, No Gain: Weight Loss, Disc Disease Interventional Radiology Treatments Coming 6
(Date:5/4/2015)... (PRWEB) May 04, 2015 Takeda Pharmaceuticals ... billion to settle thousands of Actos lawsuits ( http://www.theactoslawsuitcenter.com/ ... increases the risk that a patient will develop bladder ... 28th, if 95% of those eligible for the Actos ... 9,000 bladder cancer cases currently pending in courts around ...
(Date:5/4/2015)... NY (PRWEB) May 04, 2015 ... insurance programs, announces the expansion of coverage for its ... a leading provider of industry-tailored insurance and proactive risk ... & Company, we are dedicated to providing our customers ... meet their many evolving needs. We are excited to ...
(Date:5/4/2015)... PROVIDENCE, R.I. (PRWEB) May 04, 2015 Johnson ... new $40 million engineering and science academic center on Wednesday, ... in the ground for land made available by the re-alignment ... at the corner of Friendship and Chestnut streets in Providence, ... being built on a parcel of land the university purchased ...
(Date:5/4/2015)... 04, 2015 TROY Healthcare Solutions is ... Atlantic Regional User Group (RUG) Conference in Baltimore, MD ... Atlantic Regional User Group provides an opportunity for clients ... the exhibitor gallery. , In addition to sponsoring the ... Cerner North Atlantic RUG Conference. Attendees can stop by ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 The American ... critical state policy reports which identify gaps in coverage ... “After ATA issued the State Telemedicine Gaps Reports last ... how their laws and regulations impact healthcare delivery in ... a result of state actions across the nation, ATA ...
Breaking Medicine News(10 mins):Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 2Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 3Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 2Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 3Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 2Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 3Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 3Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 2Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 3
... The American Academy of Cosmetic Surgery (AACS) 2006 Consumer Perspective ... US citizens have had cosmetic surgery//, a great number are ... ,Jeff Knezovich, executive vice president of the American Academy ... lot since the 1970s when such surgery was rarely mentioned. ...
... 200 children were taken ill after eating lunch at their ... were admitted to a hospital and are reportedly in a ... Dianshi Town High School began reporting symptoms of headache, stomach ... Monday and were immediately hopitalised. ,The food samples ...
... Health and Family Welfare Minister Anbumani Ramadoss today officially ... The highly contagious disease was prevalent among tribals living ... Last year it was leprosy and this year it ... that India had moved closer to completely eliminating yaws ...
... Children are being exposed to the risk of liver damage ... lead and cadmium found in plastic and other soft toys ... ,"Dangerous levels of lead and cadmium have been found ... the markets," said Toxics Link, an environmental non-governmental organisation, in ...
... that caused by hay fever and other allergies, have ... without allergies, according to a report in the September ... issue on sleep. ,Allergic rhinitis, which occurs ... nasal passages, affects about 20 to 50 percent of ...
... bottles of Similac Infant Formula were off the shelf, after ... following a suspected flaw in the bottle. No repercussions after ... the company has decided to recall the product in order ... C content in the bottle. ,Given ...
Cached Medicine News:Health News:Dangers Lurking in Soft, Cuddly Toys 2Health News:Allergic Rhinitis Associated with Impaired Sleep Quality 2
... has a complete offering of cardiology catheters. ... these catheters are designed with excellent torque, ... and better push-ability, and large inner lumens ... 5, 6 and 7 French sizes with ...
Used to negotiate tortuous vessels....
Used for vascular and non-vascular applications. Tapered fixed core construction provides gradual transition to a flexible,tip. Supplied sterile in peel-open packages. Intended for one-time use....
Used to negotiate tortuous vessels....
Medicine Products: